Sleep Agents Update Warnings As FDA Seeks Further Study Of “Complex” AEs

Questions about the safety of drugs in the sedative-hypnotic class could warrant additional clinical trials to further evaluate the complex sleep-related behaviors associated with the drugs, FDA said in announcing stronger warnings for the class March 14